Skip to main content

Find Clinical Trials

Home
Conditions
High Risk Smoldering Multiple Myeloma (HR-SMM)

Clinical trial condition

High Risk Smoldering Multiple Myeloma (HR-SMM)

Explore clinical trials studying High Risk Smoldering Multiple Myeloma (HR-SMM). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

High Risk Smoldering Multiple Myeloma (HR-SMM) trial results

Recruiting

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

NCT07393282

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Emory University - Winship Cancer Institute Atlanta, Georgia, United States

Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States

View Trial Details